Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytes
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 25 (12) , 1321-1330
- https://doi.org/10.1016/0161-5890(88)90047-8
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytesEuropean Journal of Immunology, 1986
- Tissue-specific phosphorylation of complement receptors CR1 and CR2.The Journal of Experimental Medicine, 1986
- The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.Proceedings of the National Academy of Sciences, 1985
- A monoclonal antibody that blocks class II histocompatibility-related immune interactionsHuman Immunology, 1984
- Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies.The Journal of Immunology, 1983
- Biochemical comparison of the T6 antigen and HLA-A,B antigensHuman Immunology, 1983
- Expression of cell surface markers after human B lymphocyte activation.Proceedings of the National Academy of Sciences, 1981
- Characterization of a human B lymphocyte-specific antigen.The Journal of Immunology, 1980
- Structural studies of murine lymphocyte surface IgD.The Journal of Immunology, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970